Advertisement

Advertisement

OCE Insights

Issues in Oncology

Update on Project Facilitate at the Oncology Center of Excellence

Mitchell Chan, PharmD, BCPS; Tamy Kim, PharmD; Jessica Boehmer, MBA; and Richard Pazdur, MD  /  February 25, 2020

OCE Insights is an occasional department developed for The ASCO Post by members of the Oncology Center of Excellence (OCE) at the U.S. Food and Drug Administration (FDA). In this installment, Mitchell Chan, PharmD, BCPS, Regulatory Project Manager; Tamy Kim, PharmD, Associate Director of Regulatory ...

Issues in Oncology

Patient-Centered Initiatives at the FDA

The ASCO Post Staff  /  September 25, 2019

OCE Insights is a periodic column developed for The ASCO Post by members of the Oncology Center of Excellence (OCE) at the U.S. Food and Drug Administration (FDA). In this first installment, Vishal Bhatnagar, MD, Acting Associate Director of Patient Outcomes; Bellinda King-Kallimanis, PhD, Senior St...

This Year’s FDA-ASCO Workshop Focused on Collection of Patient-Reported Tolerability Data From Clinical Trials

Vishal Bhatnagar, MD; Bellinda King-Kallimanis, PhD; Paul Kluetz, MD; Heidi Klepin, MD; and Kathryn Mileham, MD  /  November 25, 2020

OCE Insights is an occasional column developed for The ASCO Post by members of the Oncology Center of Excellence (OCE) at the U.S. Food and Drug Administration (FDA). In this installment, Vishal Bhatnagar, MD, Associate Director for Patient Outcomes, Bellinda King-Kallimanis, PhD, Senior Staff Fello...

Project Socrates: An Educational Bridge From the FDA to the Public

Jennifer J. Gao, MD, and Richard Pazdur, MD  /  November 25, 2019

OCE Insights is an occasional department developed for The ASCO Post by members of the Oncology Center of Excellence (OCE) at the U.S. Food and Drug Administration (FDA). In this installment, Jennifer J. Gao, MD, Acting Associate Director of Education in the OCE, and Richard Pazdur, MD, Director of ...

Advertisement

Advertisement



Advertisement